Cargando…
Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes—a systematic review
Human-induced pluripotent stem cells (hiPSC) can be differentiated to cardiomyocytes at high efficiency and are increasingly used to study cardiac disease in a human context. This review evaluated 38 studies on hypertrophic (HCM) and dilated cardiomyopathy (DCM) of different genetic causes asking to...
Autores principales: | Eschenhagen, Thomas, Carrier, Lucie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475632/ https://www.ncbi.nlm.nih.gov/pubmed/30324321 http://dx.doi.org/10.1007/s00424-018-2214-0 |
Ejemplares similares
-
Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes
por: Eschenhagen, Thomas, et al.
Publicado: (2015) -
Human pluripotent stem cell-derived cardiomyocytes for studying energy metabolism()
por: Ulmer, Bärbel M., et al.
Publicado: (2020) -
Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies
por: Brodehl, Andreas, et al.
Publicado: (2019) -
Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research
por: Andrysiak, Kalina, et al.
Publicado: (2021) -
Importance of evaluating protein glycosylation in pluripotent stem cell-derived cardiomyocytes for research and clinical applications
por: Kelly, Maia I., et al.
Publicado: (2021)